- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Revenue of Johnson & Johnson worldwide 2011-2018, by segment
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Revenue of Johnson & Johnson worldwide 2011-2018, by segment
Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)
by Matej Mikulic,
last edited
Aug 9, 2019
The pharmaceutical segment of Johnson & Johnson was the company’s strongest segment during 2018, generating over 40 billion U.S. dollars of revenue globally. The rise of pharmaceuticals as the company’s leading segment began in 2013, when it was about even with the medical devices and diagnostics segment for the first time. Johnson & Johnson’s third pillar is the consumer health segment.
Johnson & Johnson company overview
New Jersey-based Johnson & Johnson is a global diversified healthcare company, with the pharmaceutical business becoming increasingly dominant over time. Within Johnson & Johnson’s pharmaceutical segment, oncology and immunology are the major therapeutic areas. But Johnson & Johnson also has two other strong business segments: medical devices and diagnostics, and consumer packaged goods. In fact, these segments rank J&J among the world’s top 10 medical technology companies as well as the world’s number one consumer health company.
The company’s pharmaceutical segment
Since 2013, the pharmaceutical segment showed significant growth within J&J’s segments. That the company shows particular engagement in this field is also visible by the size of its R&D pipeline which is one of the largest within the pharma industry, as of 2019. Only Novartis and Takeda showed a higher count of drugs in the pipeline. Johnson & Johnson was also ranked second worldwide based on the number of originated drugs, as of the same year. These developments are comprehensible when taking into account the company’s share of revenue which is invested into research and development. Since 2010, it has shown an almost constant increase.
Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)
| Medical Devices and Diagnostics | Pharmaceutical | Consumer | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Medical Devices and Diagnostics | Pharmaceutical | Consumer | |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 9, 2019
The pharmaceutical segment of Johnson & Johnson was the company’s strongest segment during 2018, generating over 40 billion U.S. dollars of revenue globally. The rise of pharmaceuticals as the company’s leading segment began in 2013, when it was about even with the medical devices and diagnostics segment for the first time. Johnson & Johnson’s third pillar is the consumer health segment.
Johnson & Johnson company overview
New Jersey-based Johnson & Johnson is a global diversified healthcare company, with the pharmaceutical business becoming increasingly dominant over time. Within Johnson & Johnson’s pharmaceutical segment, oncology and immunology are the major therapeutic areas. But Johnson & Johnson also has two other strong business segments: medical devices and diagnostics, and consumer packaged goods. In fact, these segments rank J&J among the world’s top 10 medical technology companies as well as the world’s number one consumer health company.
The company’s pharmaceutical segment
Since 2013, the pharmaceutical segment showed significant growth within J&J’s segments. That the company shows particular engagement in this field is also visible by the size of its R&D pipeline which is one of the largest within the pharma industry, as of 2019. Only Novartis and Takeda showed a higher count of drugs in the pipeline. Johnson & Johnson was also ranked second worldwide based on the number of originated drugs, as of the same year. These developments are comprehensible when taking into account the company’s share of revenue which is invested into research and development. Since 2010, it has shown an almost constant increase.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2011 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Johnson & Johnson's annual financial report.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2011 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Johnson & Johnson's annual financial report.
Other statistics on the topic
Johnson & Johnson
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Johnson & Johnson's number of employees 2004-2018
+Pharmaceutical Products & Market
2019 list of global top 10 biotech and pharmaceutical companies by employees
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Johnson & Johnson
- 48 page/s
- English
- pptx
- Detailed references
Everything On "Johnson & Johnson" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Johnson & Johnson"
- Global positioning
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- 2019 ranking of the global top 10 biotech and pharmaceutical companies based on employee number (in 1,000)2019 list of global top 10 biotech and pharmaceutical companies by employees
- Top 10 pharmaceutical companies worldwide by size of R&D pipeline in 2019*Top pharma companies worldwide 2019, by size of R&D pipeline
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*Top pharma companies worldwide by number of originated drugs 2019
- Revenue and income
The most important statistics
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)Revenue of Johnson & Johnson worldwide 2011-2018, by segment
- Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)Revenue of Johnson & Johnson 2006-2018 by region
- Johnson & Johnson's net income from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's net income 2005-2018
- Segments
The most important statistics
- Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2018 (in million U.S. dollars)Revenue of Johnson & Johnson's pharmaceutical products 2014-2018
- Revenue of Johnson & Johnson's medical devices and diagnostics segment from 2016 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's medical devices and diagnostics by franchise 2016-2018
- Revenue of Johnson & Johnson's consumer healthcare segment from 2014 to 2018, by franchise (in million U.S. dollars)Revenue of Johnson & Johnson's consumer healthcare segment by franchise 2014-2018
- Miscellaneous
The most important statistics
- Johnson & Johnson's expenditure on research and development from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's expenditure on research and development 2005-2018
- Johnson & Johnson's research and development expenditure as a percent of revenue from 2005 to 2018Johnson & Johnson's R&D expenditure as a percent of revenue 2005-2018
- Johnson & Johnson's number of employees from 2004 to 2018 (in 1,000)Johnson & Johnson's number of employees 2004-2018
- Brand value of Johnson & Johnson's cosmetic brands worldwide from 2017 to 2019 (in billion U.S. dollars)Brand value of Johnson & Johnson's cosmetic brands worldwide 2017-2019
- Forecasts
The most important statistics
- Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024
- Johnson & Johnson's market share of the over-the-counter and nutritionals market worldwide from 2013 to 2021*Johnson & Johnson's market share of the global OTC and nutritionals market
- Forecast of EBITDA of Johnson & Johnson for 2018 to 2020 (in million U.S. dollars)Forecast of EBITDA of Johnson & Johnson 2018-2020
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Johnson & Johnson employees involved in R&D in 2017 and 2018
- Johnson & Johnson: ad spend in Canada 2012-2013
- Revenue of Johnson & Johnson worldwide 2018-2024, by segment
- Breakdown of Johnson & Johnson's revenue worldwide 2013-2021, by sub-category
- Revenue of Johnson & Johnson's consumer health segment worldwide 2012-2024
- Total revenue of Johnson & Johnson worldwide 2012-2024
- Number of health workers educated by Johnson & Johnson globally from 2016 to 2018
- Johnson & Johnson's water use by region 2016
- Johnson & Johnson's water use by segment 2016
- Johnson & Johnson's bought energy consumption 2010-2018
- Johnson & Johnson's share of the skin care products market worldwide 2013-2021
- Chile: J&J's body care market share 2015-2016
- Leading Johnson's products in Great Britain 2018, by number of users
- Johnson & Johnson magazine ad spend in Canada 2011-2014
- Johnson & Johnson - ad spend in the U.S. 2014, by medium
- Johnson & Johnson: advertising spending worldwide 2011-2014
- Industry revenue of “Medical instruments electronic equipment“ in Japan 2011-2023
- Forecast: revenue electromedical equipment manufacture Croatia 2008-2020
- Industry revenue of “Medical instruments and apparatus“ in Japan 2011-2023
- Lafarge - revenue by region 2014
Studies
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology in Germany
- PAGB Annual Review 2017-2018
- Teva - 2018 Form 10-K
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Generic Pharmaceutical Industry Yearbook 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
Statistics on "Johnson & Johnson"
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- 2019 ranking of the global top 10 biotech and pharmaceutical companies based on employee number (in 1,000)
- Top 10 pharmaceutical companies worldwide by size of R&D pipeline in 2019*
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson worldwide from 2011 to 2018, by segment (in million U.S. dollars)
- Johnson & Johnson's revenue from 2006 to 2018, by region (in million U.S. dollars)
- Johnson & Johnson's net income from 2005 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2018 (in million U.S. dollars)
- Revenue of Johnson & Johnson's medical devices and diagnostics segment from 2016 to 2018, by franchise (in million U.S. dollars)
- Revenue of Johnson & Johnson's consumer healthcare segment from 2014 to 2018, by franchise (in million U.S. dollars)
- Johnson & Johnson's expenditure on research and development from 2005 to 2018 (in million U.S. dollars)
- Johnson & Johnson's research and development expenditure as a percent of revenue from 2005 to 2018
- Johnson & Johnson's number of employees from 2004 to 2018 (in 1,000)
- Brand value of Johnson & Johnson's cosmetic brands worldwide from 2017 to 2019 (in billion U.S. dollars)
- Revenue of Johnson & Johnson's pharmaceuticals segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)
- Johnson & Johnson's market share of the over-the-counter and nutritionals market worldwide from 2013 to 2021*
- Forecast of EBITDA of Johnson & Johnson for 2018 to 2020 (in million U.S. dollars)
- Percentage of Johnson & Johnson employees that were involved in research and development from 2017 to 2018*
- Johnson & Johnson advertising spending in Canada in 2012 and 2013 (in million Canadian dollars)
- Revenue of Johnson & Johnson worldwide from 2018 to 2024, by segment* (in billion U.S. dollars)
- Breakdown of Johnson & Johnson's revenue worldwide from 2013 to 2021, by sub-category
- Revenue of Johnson & Johnson's consumer healthcare segment worldwide from 2012 to 2024, by product category* (in billion U.S. dollars)
- Total revenue of Johnson & Johnson worldwide from 2012 to 2024 (in billion U.S. dollars)*
- Number of health workers educated worldwide through Johnson & Johnson programs from 2016 to 2018
- Water usage of Johnson & Johnson in 2016, by region (in million cubic meters)
- Water usage of Johnson & Johnson in 2016, by business segment (in million cubic meters)
- Purchased energy consumption of Johnson & Johnson from 2010 to 2018 (in terajoules)
- Johnson & Johnson's share of the skin care products market worldwide from 2013 to 2021*
- Market share of Johnson & Johnson in the body care retail market in Chile in 2015 and 2016
- Johnson's products ranked by number of users in Great Britain in 2018 (in 1,000s)
- Johnson & Johnson magazine advertising spending in Canada from 2011 to 2014 (in million Canadian dollars)
- Johnson & Johnson's direct-to-consumer (DTC) advertising spending in the United States in 2014, by medium (in million U.S. dollars)
- Johnson & Johnson's advertising spending worldwide from 2011 to 2014 (in billion U.S. dollars)
- Industry revenue of “Medical instruments electronic equipment“ in Japan from 2011 to 2023 (in billion U.S. Dollars)
- Revenue of electromedical equipment manufacture (NACE Rev. 2 C2660) in Croatia from 2008 to 2020 (in million U.S. dollars)
- Industry revenue of “Medical instruments and apparatus“ in Japan from 2011 to 2023 (in billion U.S. Dollars)
- Lafarge's revenue in FY 2014, by region
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.